Which term describes a drug's effect of increasing the force of cardiac contraction, distinct from raising heart rate or constricting blood vessels?
Choose an answer, then check it.
Clinical Pharmacology · Heart Failure and Angina Medications
Inotropes
On this page 6 sections
In 30 seconds
Inotropes make the heart squeeze harder, used short-term in acute decompensated heart failure or cardiogenic shock when the pump is failing and organs are under-perfused. Dobutamine, dopamine, and milrinone are the main agents, each boosting contractility through a different pathway with different tradeoffs in blood pressure, heart rate, and arrhythmia risk. None extends survival — they buy time toward recovery, a device, transplant, or palliation.
The college version
Inotropy, Chronotropy, and Vasopressor Effects
Three terms describe different things a cardiovascular drug can do. A positive inotrope increases the force of ventricular contraction, raising stroke volume and cardiac output without necessarily changing heart rate. A positive chronotrope increases heart rate. A vasopressor raises blood pressure primarily by constricting vessels and raising systemic vascular resistance, rather than by improving heart function. Many drugs overlap — dopamine, for example, drifts from inotropic toward vasopressor behavior depending on which receptors it engages — so the useful question is "what receptor, what effect," not lumping every cardiac stimulant together.
Dobutamine
Dobutamine is a synthetic catecholamine that predominantly stimulates beta-1 receptors, increasing contractility with only mild vasodilation from beta-2 activity. This makes it useful when cardiac output is low but blood pressure is only marginally low — it improves forward flow without sharply raising afterload. Limitations include dose-related tachycardia, atrial and ventricular arrhythmias, and increased myocardial oxygen demand that can worsen ischemia. With continuous use over days, tachyphylaxis develops as beta-receptors downregulate, blunting effectiveness.
Dopamine
Dopamine's effects fall along a dose-dependent qualitative spectrum rather than fixed numeric thresholds to memorize. At lower relative levels dopaminergic and mild beta effects predominate; at intermediate levels beta-1 stimulation produces inotropic and chronotropic effects; at higher relative levels alpha-1 vasoconstriction becomes prominent, shifting the drug toward vasopressor behavior. Because of this shifting profile, dopamine carries a notably higher arrhythmia burden than dobutamine and is used less consistently as a pure inotrope today.
Milrinone
Milrinone is a phosphodiesterase-3 (PDE-3) inhibitor, mechanistically distinct from the catecholamines. It blocks breakdown of cyclic AMP in cardiac and vascular smooth muscle, raising intracellular calcium and contractility independent of beta-receptor stimulation. Because its mechanism bypasses the beta-adrenergic pathway, milrinone stays effective in patients on chronic beta-blocker therapy, where dobutamine's benefit can be blunted. It is often called an "inodilator" because the same cAMP rise that boosts contractility also relaxes vascular smooth muscle, producing significant vasodilation. This can cause hypotension, especially in volume-depleted patients, and milrinone still carries meaningful arrhythmia risk. Because it is renally cleared, dose adjustment and caution are needed in kidney impairment, where accumulation can prolong its effects.
Levosimendan
Levosimendan is a calcium-sensitizing agent available in some countries outside the United States. Rather than raising calcium levels, it increases contractile proteins' sensitivity to calcium already present, producing inotropic support with vasodilation and less increase in oxygen demand than catecholamines typically cause.
The Core Principle and Nursing Considerations
Across all inotropes, the same caution applies: they improve hemodynamics, symptoms, and organ perfusion short-term, but increase myocardial oxygen consumption and arrhythmia risk, and none has shown a long-term mortality benefit — some data suggest possible harm with prolonged use. So inotropes are reserved as a bridge to recovery, a mechanical circulatory support device, or transplantation, or used for symptom palliation rather than as chronic disease-modifying therapy. Nursing care requires continuous cardiac (ECG) monitoring for arrhythmia, frequent or arterial blood pressure monitoring given the narrow margin between benefit and hypotension, tracking urine output as a marker of perfusion, a dedicated intravenous line to avoid interactions with other infusions, and careful titration attentive to trends rather than isolated readings, since these drugs act quickly and wear off quickly.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine the heart is a hand squeezing a water balloon to push water through a hose. Sometimes the squeeze gets weak, and not enough water reaches the rest of the house. Inotrope medicines are like a coach shouting "squeeze harder!" so more water goes through each squeeze. Dobutamine is a gentle coach who mostly just yells about squeezing. Dopamine is a coach whose instructions change with volume — sometimes about squeezing, sometimes about tightening the hose. Milrinone works differently: instead of yelling at the hand, it changes the chemistry inside the muscle so it squeezes harder on its own, which still works even if the hand wears a "calm down" glove (a beta-blocker) that would normally ignore the coach. All these coaches help for a while, but they tire the hand out faster and can make it twitch oddly (an arrhythmia), so doctors use them only briefly — while waiting for the heart to heal, a mechanical pump to be installed, or a new heart to arrive.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient on dobutamine for several days develops a blunted response to the same infusion rate that worked well initially. What phenomenon explains this, and what receptor-level change causes it?
Show answer
Tachyphylaxis from beta-receptor downregulation
With continuous beta-1 stimulation over days, heart muscle cells reduce the number of available beta-receptors on their surface, so the same dose has less to act on and produces a weaker effect than it did at first.
A patient in cardiogenic shock has low cardiac output but blood pressure that is only mildly low, and is not on a beta-blocker. Explain why dobutamine might be a reasonable initial choice compared to a drug with strong vasoconstrictive effects.
Show answer
Dobutamine boosts pump strength without crashing blood pressure
Dobutamine mainly stimulates beta-1 receptors to increase contractility while causing only mild vasodilation, so it can raise cardiac output without pushing an already marginal blood pressure lower, unlike a strong vasoconstrictor which would raise the workload the weak heart pumps against.
Quick check
3 questions here. Answers stay hidden until you check.
Why does milrinone remain effective in a patient taking a chronic beta-blocker, while dobutamine's effect may be blunted?
Choose an answer, then check it.
Which statement about inotrope therapy in heart failure is accurate?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.